Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exercise Training and Medication in Metabolic Syndrome
NCT03019796Phase 1Completed
- Sponsor
- Universidad de Castilla-La Mancha
- Start
- Jul 2015
- Primary completion
- Apr 2018
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in metabolic syndrome and hypertension (HTN) (2 arms), sponsored by Universidad de Castilla-La Mancha. Primary endpoints: Systolic Blood Pressure at 4 months, Diastolic Blood Pressure at 4 months and 1 more. Started Jul 2015; status: completed.
02
Conditions
metabolic syndromehypertension (HTN)
Beyond the preview
Go deeper on NCT03019796.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03019796.